YJR140W-A Antibody

What is YJR140W-A and why is it significant in yeast research?

YJR140W-A is a protein-coding gene found in Saccharomyces cerevisiae (baker's yeast), specifically in the strain ATCC 204508/S288c. This gene is of particular interest in yeast research because S. cerevisiae serves as an important model organism for understanding fundamental eukaryotic cellular processes . The protein encoded by YJR140W-A can be studied using specific antibodies that recognize and bind to the target protein, facilitating its detection in various experimental applications . S. cerevisiae is selected for molecular research due to its simple cellular organization, making it valuable for detecting novel molecular processes that may have analogs in more complex organisms .

What are the optimal storage conditions for YJR140W-A antibody to maintain its functionality?

YJR140W-A antibody should be stored at -20°C or -80°C immediately upon receipt . Repeated freeze-thaw cycles should be strictly avoided as they can lead to protein denaturation and loss of antibody functionality . For working solutions that will be used within a short timeframe, storage at 4°C is acceptable, but for long-term preservation, aliquoting the antibody before freezing is recommended to prevent the need for multiple freeze-thaw cycles. The antibody is typically supplied in a storage buffer containing 50% glycerol, 0.01M PBS, pH 7.4, with 0.03% Proclin 300 as a preservative . This formulation helps maintain antibody stability during storage.

What experimental applications is the YJR140W-A antibody validated for?

The YJR140W-A antibody (CSB-PA851573XA01SVG) has been validated for use in Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications . These methods are fundamental in protein research, with ELISA being useful for quantitative detection of the target in solutions, while Western Blot allows for size-based separation and semi-quantitative analysis of the protein in cell or tissue lysates. The antibody has been specifically tested for reactivity with Saccharomyces cerevisiae (strain ATCC 204508/S288c) . Researchers should note that this antibody is intended for research use only and not for diagnostic or therapeutic procedures .

How should experimental design be approached when using YJR140W-A antibody in yeast stress response studies?

When designing experiments to study stress response in yeast using YJR140W-A antibody, researchers should consider a factorial experimental design that accounts for multiple variables and their interactions . The approach should include:

• Control selection: Include both positive controls (known inducers of the protein of interest) and negative controls (conditions where the protein is not expected to be expressed).

• Time course analysis: Plan for sampling at multiple time points to capture the dynamics of protein expression following stress exposure.

• Dose-response relationships: When applying stressors, use a range of concentrations to establish dose-dependent effects.

• Replication strategy: Implement both biological replicates (different yeast cultures) and technical replicates (repeated measurements) to ensure statistical robustness .

• Data analysis planning: Pre-determine appropriate statistical methods for analyzing complex datasets, such as ANOVA for multiple condition comparisons or regression analysis for dose-response relationships .

For validating results, researchers should consider supplementing antibody-based detection with complementary techniques such as RNA-seq to correlate protein detection with gene expression profiles .

What methodological considerations are important when optimizing Western blot protocols for YJR140W-A detection?

Optimizing Western blot protocols for YJR140W-A detection requires careful consideration of several key parameters:

• Sample preparation: For yeast cells, effective lysis is critical. Consider using mechanical disruption (glass beads) combined with detergent-based buffers containing protease inhibitors to prevent protein degradation.

• Protein loading: Determine the optimal amount of total protein to load (typically 20-50 μg for yeast lysates) through preliminary titration experiments.

• Antibody dilution optimization: Test a range of primary antibody dilutions (starting with manufacturer's recommendation) to identify the concentration that provides optimal signal-to-noise ratio.

• Blocking conditions: Evaluate different blocking agents (BSA vs. non-fat dry milk) and concentrations (3-5%) to minimize background without compromising specific signal.

• Incubation parameters: Optimize both temperature and duration for primary antibody incubation (4°C overnight vs. room temperature for shorter periods).

• Detection system selection: Choose between chemiluminescence, fluorescence, or chromogenic detection based on required sensitivity and quantification needs.

• Validation controls: Include positive controls (recombinant YJR140W-A protein), negative controls (lysates from deletion strains), and loading controls (housekeeping proteins) to ensure result reliability.

The optimal conditions should be systematically determined through controlled experiments where a single variable is modified at a time while keeping others constant.

How can researchers effectively design co-immunoprecipitation experiments with YJR140W-A antibody to study protein-protein interactions?

Designing effective co-immunoprecipitation (Co-IP) experiments with YJR140W-A antibody requires careful planning:

• Crosslinking decision: Determine whether to use chemical crosslinking (e.g., formaldehyde) to stabilize transient interactions, weighing the benefits of capturing fleeting interactions against the risk of non-specific crosslinking.

• Lysis buffer optimization: Test different buffer compositions, adjusting salt concentration (150-500 mM), detergent type (Triton X-100, NP-40, CHAPS), and pH to preserve interactions while effectively lysing cells.

• Pre-clearing strategy: Implement a pre-clearing step using protein A/G beads to reduce non-specific binding.

• Antibody conjugation approach: Choose between direct antibody conjugation to beads versus a two-step process using protein A/G beads to capture the antibody-protein complex. For YJR140W-A antibody, which is a rabbit polyclonal IgG , protein A beads would be appropriate.

• Control design:

  • Negative controls: Perform parallel IPs with non-specific rabbit IgG

  • Input controls: Save a portion of the pre-IP lysate

  • Validation controls: If available, use yeast strains with tagged versions of YJR140W-A

• Elution conditions: Optimize elution conditions to efficiently release the protein complexes without contamination from the antibody chains.

• Downstream analysis: Plan for appropriate detection methods for interacting partners, such as mass spectrometry for unbiased discovery or targeted Western blot if specific interactions are hypothesized.

The quality of the antibody is paramount for successful Co-IP experiments, and the antigen affinity purification of this YJR140W-A antibody makes it potentially suitable for such applications.

How can YJR140W-A antibody be utilized in programmed cell death studies in yeast models?

YJR140W-A antibody can be strategically employed in programmed cell death studies in yeast through several sophisticated approaches:

• Temporal protein expression profiling: Design time-course experiments to track YJR140W-A protein levels during apoptotic progression using quantitative Western blot analysis. This approach aligns with research methodologies used to identify early molecular markers of programmed cell death in S. cerevisiae .

• Co-localization studies: Combine the YJR140W-A antibody with fluorescently-labeled antibodies against known apoptotic markers in immunofluorescence microscopy to establish spatial relationships during cell death progression.

• Stress response comparison: Design parallel experiments examining YJR140W-A expression under both apoptotic conditions and non-lethal stress conditions. This comparative approach can help distinguish whether the protein is specifically involved in programmed cell death or represents a general stress response, similar to the methodology described for identifying genes with opposite expression trends in programmed cell death versus stress response .

• Functional validation: Couple antibody-based detection with genetic approaches such as gene deletion or overexpression to establish causative relationships between YJR140W-A and cell death phenotypes.

• Pathway analysis: Use the antibody in combination with inhibitors of specific apoptotic pathways to determine where YJR140W-A functions in the cell death cascade, potentially exploring connections to known yeast apoptotic mechanisms involving ATF4 and CHOP homologs .

This multi-faceted approach leverages the specificity of the YJR140W-A antibody while incorporating it into a comprehensive experimental design aimed at elucidating functional roles in programmed cell death.

What approaches can resolve inconsistent YJR140W-A antibody detection results across different experimental conditions?

When faced with inconsistent YJR140W-A antibody detection results, researchers should implement a systematic troubleshooting approach:

• Antibody validation reassessment:

  • Confirm antibody specificity using positive controls (recombinant YJR140W-A protein)

  • Validate using negative controls (YJR140W-A deletion strains)

  • Consider epitope mapping to understand potential interference from protein modifications

• Sample preparation optimization:

  • Compare different lysis methods (mechanical vs. enzymatic for yeast cells)

  • Test multiple buffer compositions with varying detergent concentrations

  • Implement protease and phosphatase inhibitor cocktails to prevent degradation

  • Standardize protein quantification methods for consistent loading

• Experimental condition standardization:

  • Control for yeast growth phase (log vs. stationary) which can affect protein expression

  • Standardize stress induction protocols with precise timing and dosage

  • Document and control environmental variables (temperature, media composition)

• Technical parameter adjustment:

  • Systematically vary antibody concentration, incubation time, and temperature

  • Test different blocking agents and washing stringency

  • Compare multiple detection systems (HRP-based vs. fluorescent)

• Statistical robustness implementation:

  • Increase biological replicates to account for natural variation

  • Apply appropriate statistical tests to determine significant differences

  • Develop standardized quantification protocols for densitometry analysis

• Cross-validation with orthogonal methods:

  • Complement antibody-based detection with RNA expression analysis

  • Consider mass spectrometry-based protein identification

  • Use tagged versions of the protein as alternative detection strategy

By documenting each variable systematically in a troubleshooting matrix, researchers can isolate factors contributing to inconsistency and develop a robust, reproducible protocol.

How can researchers integrate YJR140W-A antibody data with transcriptomic analyses for comprehensive pathway elucidation?

Integration of YJR140W-A antibody-derived protein data with transcriptomic analyses requires a sophisticated multi-omics approach:

• Experimental design for integrated analysis:

  • Design experiments with matched samples for both protein detection (using YJR140W-A antibody) and RNA extraction

  • Include appropriate time points to capture both immediate transcriptional changes and subsequent translational responses

  • Ensure sufficient biological replicates for statistical power in both proteomic and transcriptomic datasets

• Data generation and normalization:

  • Quantify YJR140W-A protein levels using calibrated Western blot or ELISA protocols

  • Process RNA-seq data using standardized pipelines for differential expression analysis

  • Apply appropriate normalization methods for each data type before integration

• Correlation analysis approaches:

  • Calculate Pearson or Spearman correlation coefficients between YJR140W-A protein levels and mRNA expression of related genes

  • Implement time-lagged correlation analyses to account for delays between transcription and translation

  • Apply sliding window analyses to identify optimal time offsets for maximum correlation

• Pathway reconstruction methods:

  • Use protein-protein interaction databases to place YJR140W-A in biological context

  • Apply algorithms such as weighted gene co-expression network analysis (WGCNA) to identify modules of co-regulated genes

  • Integrate with existing pathway knowledge using gene set enrichment analysis

• Visualization and interpretation strategies:

  • Develop integrated visualizations showing both transcriptomic and proteomic data

  • Apply dimensionality reduction techniques (PCA, t-SNE) for pattern discovery

  • Use causal network inference to propose directionality in regulatory relationships

• Validation approaches:

  • Design targeted validation experiments based on computational predictions

  • Use genetic perturbation (e.g., CRISPR-based approaches) to confirm proposed pathway relationships

  • Consider complementary proteomics approaches for broader protein interaction studies

This integrated approach aligns with current best practices in systems biology and functional genomics research as demonstrated in studies examining S. cerevisiae molecular responses .

How does antibody detection of YJR140W-A compare between different stress conditions in yeast models?

Comparative analysis of YJR140W-A detection across different stress conditions requires a carefully designed experimental approach:

• Stress condition matrix design:

  • Select diverse stress types: oxidative (H₂O₂), osmotic (NaCl), heat shock, nutrient deprivation, and chemical stressors

  • Implement a gradient of intensities for each stress type

  • Include combination stresses to identify potential synergistic or antagonistic effects

• Standardized detection protocol:

  • Use identical sample processing and Western blot conditions across all stress types

  • Implement internal loading controls for normalization

  • Include calibration standards on each blot for cross-blot comparability

• Quantitative analysis approach:

  • Apply densitometric analysis with appropriate software

  • Normalize YJR140W-A signal to loading controls

  • Calculate fold-change relative to unstressed controls

• Statistical comparison framework:

  • Implement two-way ANOVA to evaluate effects of stress type and intensity

  • Apply post-hoc tests for specific comparisons between conditions

  • Utilize regression analysis for dose-response relationships

• Temporal dynamics consideration:

  • Collect samples at multiple time points post-stress induction

  • Analyze both immediate and adaptive responses

  • Develop time-course profiles for each stress condition

This approach would reveal whether YJR140W-A responds differentially to specific stressors or represents a general stress response element, similar to the approach used in distinguishing programmed cell death markers from general stress response genes . The resulting data could identify specific stressors that modulate YJR140W-A expression most significantly, providing insights into its functional role in cellular stress pathways.

What considerations are important when analyzing post-translational modifications of YJR140W-A using immunological methods?

Analysis of post-translational modifications (PTMs) of YJR140W-A requires specialized approaches beyond standard antibody detection:

• PTM-specific antibody selection and validation:

  • Determine which PTMs are biologically relevant for YJR140W-A through bioinformatic prediction

  • Select or develop antibodies specific to phosphorylated, ubiquitinated, or other modified forms

  • Validate PTM-specific antibodies using appropriate controls (e.g., phosphatase-treated samples)

• Sample preparation optimization for PTM preservation:

  • Incorporate phosphatase inhibitors (for phosphorylation studies)

  • Add deubiquitinating enzyme inhibitors (for ubiquitination studies)

  • Use rapid lysis protocols to minimize PTM loss during processing

  • Consider crosslinking approaches for preserving transient modifications

• Enrichment strategies for low-abundance modified forms:

  • Implement immunoprecipitation with the YJR140W-A antibody followed by PTM-specific detection

  • Use affinity purification techniques specific to certain PTMs (e.g., phosphopeptide enrichment)

  • Consider two-dimensional gel electrophoresis to separate modified from unmodified forms

• Advanced detection methods:

  • Apply Phos-tag™ SDS-PAGE for mobility shift detection of phosphorylated forms

  • Utilize 2D-immunoblotting with pH gradient in the first dimension to resolve modified variants

  • Consider mass spectrometry for precise identification of modification sites

• Functional correlation approaches:

  • Design experiments correlating PTM status with functional outcomes

  • Manipulate cellular conditions known to affect specific PTMs

  • Couple with genetic approaches using phosphomimetic or phospho-dead mutations

• Quantitative analysis considerations:

  • Develop ratiometric methods comparing modified to total protein levels

  • Apply appropriate statistical approaches for comparing PTM levels across conditions

  • Account for potential antibody affinity differences between modified and unmodified forms

This comprehensive approach would provide insights into how post-translational regulation affects YJR140W-A function under different cellular conditions, potentially revealing regulatory mechanisms controlling its activity or stability.

How can researchers design experiments to investigate the role of YJR140W-A in yeast bioreactor and industrial applications?

Designing experiments to investigate YJR140W-A's role in bioreactor and industrial applications requires bridging fundamental research with applied biotechnology:

• Strain engineering and comparative analysis:

  • Create YJR140W-A deletion, overexpression, and tagged variants in industrial yeast strains

  • Design parallel fermentations comparing engineered strains under identical conditions

  • Monitor growth parameters, metabolite production, and process efficiency

• Bioprocess parameter optimization:

  • Implement Design of Experiments (DoE) approach to systematically vary temperature, pH, aeration, and substrate concentration

  • Monitor YJR140W-A expression levels across different process conditions using the antibody

  • Correlate expression patterns with bioprocess performance metrics

• Stress response characterization under industrial conditions:

  • Simulate industrial stressors (ethanol toxicity, osmotic pressure, substrate inhibition)

  • Monitor YJR140W-A expression dynamics during stress response using time-course sampling

  • Develop predictive models correlating expression patterns with culture outcomes

• Scale-up considerations:

  • Design experiments at multiple scales (lab, pilot, production)

  • Investigate whether YJR140W-A expression changes with scaling parameters

  • Develop correction factors for antibody-based monitoring across scales

• Real-time monitoring approaches:

  • Investigate reporter systems linked to YJR140W-A promoter as potential bioprocess sensors

  • Correlate antibody-detected protein levels with reporter system output

  • Evaluate potential for developing real-time monitoring based on expression dynamics

• Process optimization strategies:

  • Use knowledge of YJR140W-A function to design feeding strategies or process interventions

  • Implement adaptive control based on expression patterns

  • Develop predictive models for process outcomes based on early expression signatures

This experimental framework connects fundamental research on YJR140W-A with practical applications in bioprocessing, potentially leading to improved monitoring tools or strain optimization strategies for industrial yeast fermentations, as suggested by research on cellular response monitoring in bioreactors .

How might single-cell analysis techniques be applied with YJR140W-A antibody to understand population heterogeneity in yeast cultures?

Applying single-cell analysis techniques with YJR140W-A antibody opens new avenues for understanding population heterogeneity:

• Flow cytometry adaptation for yeast cells:

  • Optimize cell fixation and permeabilization protocols for intracellular YJR140W-A detection

  • Develop fluorophore-conjugated secondary antibodies or directly labeled YJR140W-A antibodies

  • Implement multiparameter analysis combining YJR140W-A detection with viability markers and cell cycle indicators

  • Apply statistical methods for population distribution analysis and subpopulation identification

• Mass cytometry (CyTOF) application:

  • Develop metal-tagged YJR140W-A antibodies compatible with mass cytometry

  • Design panels including markers for stress response, metabolic state, and cell cycle

  • Apply high-dimensional data analysis algorithms (t-SNE, UMAP) to identify distinct cellular states

  • Correlate YJR140W-A expression with other cellular parameters at single-cell resolution

• Single-cell immunofluorescence microscopy approaches:

  • Design microfluidic devices for yeast cell immobilization and imaging

  • Implement automated image acquisition and analysis workflows

  • Quantify subcellular localization patterns of YJR140W-A across thousands of individual cells

  • Correlate protein expression with morphological features and cell cycle stages

• Integration with single-cell transcriptomics:

  • Develop protocols for antibody-based protein detection compatible with scRNA-seq workflows

  • Apply CITE-seq or similar approaches for simultaneous measurement of YJR140W-A protein and transcriptome

  • Analyze protein-mRNA correlations at single-cell level to identify post-transcriptional regulation

• Spatial analysis in yeast colonies:

  • Apply immunohistochemistry to sections of yeast colonies or biofilms

  • Map spatial distribution of YJR140W-A expression across structured yeast communities

  • Correlate expression patterns with spatial position and microenvironmental conditions

These approaches would reveal how YJR140W-A expression varies across individual cells within populations, potentially identifying subpopulations with distinct phenotypic characteristics or stress responses that might be masked in bulk analyses, similar to single-cell approaches used in human cell studies .

What are the considerations for developing CRISPR-based functional genomics studies to complement YJR140W-A antibody research?

Developing CRISPR-based functional genomics approaches to complement YJR140W-A antibody research requires careful consideration of several factors:

• CRISPR system adaptation for S. cerevisiae:

  • Select appropriate CRISPR-Cas variants optimized for yeast systems

  • Design efficient guide RNA delivery methods (plasmid-based or direct RNA delivery)

  • Optimize homology-directed repair templates for precise genetic modifications

  • Consider the compact yeast genome when designing guides to minimize off-target effects

• Experimental design strategies:

  • Create knockout strains to validate antibody specificity

  • Develop knock-in strains with epitope tags for orthogonal detection methods

  • Generate conditional expression systems (e.g., degron-tagged variants) for temporal control

  • Design allelic series with point mutations to map functional domains and PTM sites

• Genome-wide screening approaches:

  • Develop pooled CRISPR screens to identify genetic interactions with YJR140W-A

  • Implement synthetic genetic array (SGA) analysis with CRISPR-modified strains

  • Design reporter systems to monitor YJR140W-A expression or function in high-throughput screens

  • Apply barcode sequencing for quantitative phenotypic analysis of mutant pools

• Integration with antibody-based detection:

  • Validate CRISPR modifications using the YJR140W-A antibody

  • Combine genetic perturbations with quantitative Western blot analysis

  • Design experiments to distinguish direct from indirect effects on protein levels

  • Use antibody-based methods to validate findings from genetic screens

• Advanced genetic manipulation strategies:

  • Implement base editing for precise nucleotide changes without double-strand breaks

  • Apply CRISPRi/CRISPRa for reversible modulation of YJR140W-A expression

  • Develop multiplexed CRISPR systems for simultaneous modification of YJR140W-A and interacting partners

  • Consider prime editing for scarless genetic modifications

This integrated approach would provide complementary genetic and protein-level data, allowing researchers to distinguish between transcriptional, translational, and post-translational effects on YJR140W-A function, similar to integrated approaches used in functional genomics studies .

How can computational modeling be integrated with YJR140W-A antibody data to predict protein function in complex cellular networks?

Integrating computational modeling with YJR140W-A antibody data can create powerful predictive frameworks:

• Data integration for model construction:

  • Combine quantitative YJR140W-A protein levels from antibody-based detection with transcriptomic, proteomic, and metabolomic datasets

  • Normalize and transform heterogeneous data types for computational compatibility

  • Apply feature selection algorithms to identify most informative parameters for modeling

• Network reconstruction approaches:

  • Utilize protein-protein interaction data to place YJR140W-A in its interaction context

  • Apply Bayesian network inference to propose causal relationships

  • Implement mutual information-based approaches to detect non-linear relationships

  • Integrate prior knowledge from literature with experimental data using hybrid modeling approaches

• Dynamic modeling strategies:

  • Develop ordinary differential equation (ODE) models incorporating YJR140W-A regulation

  • Implement stochastic modeling approaches to account for cell-to-cell variability

  • Apply constraint-based modeling (e.g., flux balance analysis) to understand metabolic impacts

  • Develop agent-based models for multicellular systems or colony behaviors

• Model validation and refinement:

  • Design targeted experiments to test specific model predictions

  • Implement iterative model refinement based on new antibody-derived data

  • Apply sensitivity analysis to identify critical parameters and potential intervention points

  • Develop ensemble modeling approaches to account for parameter uncertainty

• Predictive applications:

  • Use trained models to predict cellular responses to novel perturbations

  • Design optimized experimental conditions based on model predictions

  • Identify potential synthetic lethal interactions for targeted follow-up experiments

  • Develop in silico screening approaches to prioritize genetic or chemical interventions

• Visualization and interpretation tools:

  • Create interactive network visualizations incorporating antibody-derived expression data

  • Implement pathway enrichment analysis to place findings in biological context

  • Develop user-friendly interfaces for hypothesis exploration and model interrogation